APPLICATION OF THE ASSOCIATION OF THE CURRENT NODE INHIBITOR OF THE CURRENT AND THE INHIBITOR OF THE ANGIOTENZIN-TURNING ENZYME INHIBITOR FOR TREATING HEART FAILURE

摘要

The use of the association of a selective and specific sinus node current inhibitor I, in particular ivabradine or N - {[(7S) -3,4-dimethoxybicyclo [4.2.0] octa-1,3,5-trien-7-yl] methyl} - 3- (7,8-dimethoxy-1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl) -N-methyl-3-oxo-1-propanamine, and an agent that inhibits angiotensin converting an enzyme for the production of medicines intended for the treatment of heart failure, more specifically, heart failure, which has preserved systolic function. Medicines